Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit
- 239 Downloads
A poorer functional status at the time of fracture is a predictor of non-adherence to oral bisphosphonates initiated after a hip fracture, and suggests further opportunities for optimization of secondary fracture prevention in this high-risk population.
Low adherence to treatment is a problem in post-fracture secondary prevention. We aimed to analyze the prognostic factors (related and predictive) associated with non-adherence to oral bisphosphonate prescription for hip fracture due to bone fragility (HFBF) 12 months after discharge from an acute geriatric unit.
Prospective study of bivariate data analyzing related and multivariate factors predicting non-adherence of oral bisphosphonates at 12 months after treatment for HFBF. The statistical study was performed with SPSS 19.0.0.
We attended 368 patients with HFBF. At discharge, oral bisphosphonates were prescribed to 226 (61.42%) patients. At 12 months, we followed up 160 (70.7%) patients, 104 (65%) of whom had non-adherence to oral bisphosphonates. Bivariate analysis (adherent vs. non-adherent): age (83.79 ± 5.82 vs. 85.78 ± 5.80, p = .029); Lawton and Brody Index (4.29 ± 3.40 vs. 2.67 ± 3.31, p = .004); baseline Barthel Index (BI) (85.89 ± 21.99 vs. 74.18 ± 26.70) (p = .004); BI at admission (18.84 ± 10.00 vs. 14.47 ± 11.71, p = .004); BI at discharge (34.20 ± 15.40 vs. 27.45 ± 16.71, p = .011); baseline Functional Ambulation Classification (5.66 ± 0.98 vs. 5.43 ± 0.99, p = .025). Multivariate analysis: BI 0.980 (0.965–0.995, p = .007). Discriminatory capacity of the AUC model (± 95% CI): 0.634 (0.545–0.722).
At 12 months, there was low adherence to treatment with oral bisphosphonates in our model. A lower BI prior to treatment is a predictive factor for non-adherence treatment with oral bisphosphonate.
KeywordsAdherence to oral bisphosphonates Hip fracture due to fragility Orthogeriatric Osteoporosis Secondary prevention
Compliance with ethical standards
The study was performed following the principles of the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Bellvitge Hospital (PR197/13).
Conflicts of interest
- 2.Ross S, Samuels E, Gairy K, Iqbal S, Badamgarav E, Siris E. A meta-analysis of osteoporotic fracture risk with medication nonadherence. Value Health 2011;14(4):571–581. Available from: https://doi.org/10.1016/j.jval.2010.11.010
- 6.Mears SC, Kates SL (2015) A guide to improving the Care of Patients with fragility fractures, edition 2. Geriatr Orthop Surg Rehabil 6(2):58–120 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26246957%5Cn http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4430408 CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Nanjayan SK, John J, Swamy G, Mitsiou K, Tambe A, Abuzakuk T. Predictors of change in “discharge destination” following treatment for fracture neck of femur. Injury 2014;45(7):1080–1084. Available from: https://doi.org/10.1016/j.injury.2014.02.005
- 8.Tarazona-Santabalbina FJ, Belenguer-Varea Á, Rovira E, Cuesta-Peredó D (2016) Orthogeriatric care: improving patient outcomes. Clin Interv Aging 11:843–856. https://doi.org/10.2147/CIA.S72436
- 10.Prestmo A, Hagen G, Sletvold O, Helbostad JL, Thingstad P, Taraldsen K, et al. Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial. Lancet. 2015;385(9978):1623–1633. Available from: https://doi.org/10.1016/S0140-6736(14)62409-0
- 11.Henderson CY, Shanahan E, Butler A, Lenehan B, O’Connor M, Lyons D et al (2016) Dedicated orthogeriatric service reduces hip fracture mortality. Ir J Med Sci:1–6Google Scholar
- 12.Duaso E, Formiga F, Marimón P, Sandiumenge M, Salgado MT, Murga V, Gamboa A, Rodriguez C, Castellà J, Escalante E, Lumbreras C, Tarrida A, Sellarès R (2018) Advantages of care for patients with hip fractures in the acute geriatric unit: hip study Anoia. Geriatr Gerontol Int 18(3):407–414CrossRefPubMedGoogle Scholar
- 14.Nogués X, Martinez-Laguna D. Tratamiento de la osteoporosis. Med Clin (Barc). 2017;(xx). Available from: https://doi.org/10.1016/j.medcli.2017.10.019
- 16.Kim SC, Kim M, Song HJ, Liu J, Hurtado I, Lee J et al (2016) Fracture: a Cross-National Study. 128(5):519–526Google Scholar
- 17.Flais J, Coiffier G, Le Noach J, Albert JD, Faccin M, Perdriger A et al (2017) Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture. Arch Osteoporos 12(1):24 Available from: http://link.springer.com/10.1007/s11657-017-0317-4 CrossRefPubMedGoogle Scholar
- 27.Hsu CY, Chiu WC, Chen JF, Chou CL, Su YJ, Yu SF, Cheng TT Medical specialty-related adherence to anti-osteoporotic regimens in fragility hip fracture patients. J Bone Miner Metab. 2014;33(5):577–583. Available from: https://doi.org/10.1007/s00774-014-0621-7
- 28.Petrella RJ, Jones TJ (2006) Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Fam Pract 7:31 Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L44139182%5Cn http://www.biomedcentral.com/content/pdf/1471-2296-7- 31.pdf%5Cnhttp://dx.doi.org/10.1186/1471-2296-7-31%5Cn http://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=14712296&id=d CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR et al (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24(2):393–406 Available from: http://link.springer.com/10.1007/s00198-012-2090-y CrossRefPubMedGoogle Scholar
- 32.Folbert EC, Hegeman JH, Vermeer M, Regtuijt EM, van der Velde D, Ten Duis HJ, et al. Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment. Osteoporos Int. 2016;1–9. Available from: https://doi.org/10.1007/s00198-016-3711-7
- 33.Schaller F, Sidelnikov E, Theiler R, Egli A, Staehelin HB, Dick W, Dawson-Hughes B, Grob D, Platz A, Can U, Bischoff-Ferrari HA Mild to moderate cognitive impairment is a major risk factor for mortality and nursing home admission in the first year after hip fracture. Bone. 2012;51(3):347–352. Available from: https://doi.org/10.1016/j.bone.2012.06.004
- 34.Fukui N, Watanabe Y, Nakano T, Sawaguchi T, Matsushita T (2012) Predictors for ambulatory ability and the change in ADL after hip fracture in patients with different levels of mobility before injury: a 1-year prospective cohort study. J Orthop Trauma 26(3):163–171 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21918484 CrossRefPubMedGoogle Scholar